Prothena Corp Public (PRTA) Intangibles (2012 - 2013)
Prothena Corp Public (PRTA) posted quarterly Intangibles of $44000.0 for Q1 2013, down 10.2% quarter-over-quarter from $49000.0 in Q4 2012.
Prothena Corp Public (PRTA) Intangibles (2012 - 2013) Analysis & Trends
Prothena Corp Public's Intangibles history runs 2 years deep, the most recent figure standing at $44000.0 for Q1 2013.
- In Q1 2013, Intangibles changed N/A year-over-year to $44000.0; the TTM figure through Mar 2013 stood at $44000.0 (changed N/A YoY), while the FY2012 annual figure was $49000.0, changed N/A from the prior year.
- Intangibles for Q1 2013 stood at $44000.0, down from $49000.0 in the prior quarter.
- The five-year high for Intangibles was $49000.0 in Q4 2012, with the low at $44000.0 in Q1 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 266.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 63.28 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 60.96 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 93.49 Mn |
| 10 | Prothena Corp Public | 458.45 Mn | 170.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 44,000.00 |
| Dec 31, 2012 | 49,000.00 |